Literature DB >> 26707765

Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem.

John Agzarian1, Waël C Hanna1, Laura Schneider1, Colin Schieman1, Christian J Finley1, Yury Peysakhovich1, Terri Schnurr2, Dennis Nguyen-Do1, Lori-Ann Linkins2, James Douketis2, Mark Crowther2, Marc De Perrot3, Thomas K Waddell3, Yaron Shargall4.   

Abstract

OBJECTIVES: To determine the prevalence of delayed postoperative venous thromboembolism (VTE) in patients undergoing oncologic lung resections, despite adherence to current in-hospital VTE prophylaxis guidelines.
METHODS: Patients undergoing lung resection for malignancy in 2 tertiary-care centers were recruited between June 2013 and December 2014. All patients received guideline-based VTE prophylaxis until hospital discharge. Patients underwent computed tomography chest angiography with pulmonary embolism (PE) protocol and bilateral lower extremity venous Doppler ultrasonography at 30 ± 5 days after surgery to determine the incidence of postoperative VTE. Univariate analysis was used to compare the VTE and non-VTE groups.
RESULTS: A total of 157 patients were included, 45.9% were men with a mean age of 66.7 years. VTE prevalence was 12.1% with a total of 19 VTE events, including 14 PEs (8.9%), 3 deep venous thromboses (DVTs) (1.9%), 1 combined PE/DVT, and 1 massive left atrial thrombus originating from the pulmonary vein stump after pulmonary lobectomy. PE events occurred in the operated lung 64% of the time and 4 patients (21.1%) were symptomatic at diagnosis. The 30-day mortality rate of VTE events was 5.2%, with 1 patient who died secondary to massive in situ ipsilateral PE following readmission to the hospital. Univariate analysis did not demonstrate significant differences between the VTE and non-VTE populations with regard to baseline characteristics.
CONCLUSIONS: Despite adherence to in-hospital standard prophylaxis guidelines, VTE events are frequent, often asymptomatic, and with associated significant morbidity and mortality. More research into the potential role of predischarge screening and extended prophylaxis is warranted.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  deep vein thrombosis; lung cancer resection; prevalence; pulmonary embolism; screening

Mesh:

Substances:

Year:  2015        PMID: 26707765     DOI: 10.1016/j.jtcvs.2015.11.038

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

Review 1.  The Society for Translational Medicine: the assessment and prevention of venous thromboembolism after lung cancer surgery.

Authors:  Hui Li; Gening Jiang; Servet Bölükbas; Chun Chen; Haiquan Chen; Keneng Chen; Jun Chen; Xiangli Cui; Wentao Fang; Shugeng Gao; Sebastien Gilbert; Jianhua Fu; Xiangning Fu; Yasuhiro Hida; Shanqing Li; Xiaofei Li; Yin Li; Hecheng Li; Yongjun Li; Deruo Liu; Lunxu Liu; Jianxing He; Jie He; Giuseppe Marulli; Hiroyuki Oizumi; Marc de Perrot; René Horsleben Petersen; Yaron Shargall; Alan Sihoe; Qunyou Tan; Qun Wang; Shun Xu; Mei Yang; Yuanhua Yang; Zhentao Yu; Lanjun Zhang; Xun Zhang; Heng Zhao; Xiuyi Zhi
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

2.  Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey.

Authors:  John Agzarian; Lori-Ann Linkins; Laura Schneider; Waël C Hanna; Christian J Finley; Colin Schieman; Marc De Perrot; Mark Crowther; James Douketis; Yaron Shargall
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

3.  Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma.

Authors:  Luis E De León; Carlos E Bravo-Iñiguez; Sam Fox; Jeffrey Tarascio; Samuel Freyaldenhoven; Moshe Lapidot; Michael T Jaklitsch; Raphael Bueno
Journal:  J Thorac Cardiovasc Surg       Date:  2020-01-30       Impact factor: 5.209

Review 4.  European perspectives in Thoracic Surgery, the ESTS venous thromboembolism (VTE) working group.

Authors:  Yaron Shargall; Virginia R Litle
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

5.  The emergence of a postoperative myocardial injury epidemic: true or false?

Authors:  W Scott Beattie
Journal:  Can J Anaesth       Date:  2021-05-18       Impact factor: 6.713

6.  Postoperative venous thromboembolism after surgery for stage IA non-small-cell lung cancer: A single-center, prospective cohort study.

Authors:  Honghong Dong; Xiaoning Liang; Yingdi Gao; Yongsheng Cai; Xinyang Li; Jinbai Miao; Wenjiao Wang; Bin Hu; Hui Li
Journal:  Thorac Cancer       Date:  2022-03-22       Impact factor: 3.223

7.  Incidence and clinical features of the incidentally found vascular stump thrombus during routine follow up after oncologic lung surgery.

Authors:  Mi Hyoung Moon; Kyongmin Sarah Beck; Young Kyu Moon; Jae Kil Park; Sook Whan Sung
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

8.  High Occurrence of Thrombo-Embolic Complications During Long-Term Follow-up After Pleural Infections-A Single-Center Experience with 536 Consecutive Patients Over 17 Years.

Authors:  Henna Maria Ala-Seppälä; Mika Tapani Ukkonen; Antti Ilmari Lehtomäki; Emilia Susanna Pohja; Jaakko Juhani Nieminen; Jari Olavi Laurikka; Jahangir Ari Khan
Journal:  Lung       Date:  2020-06-30       Impact factor: 2.584

9.  [Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Epidemiological Characteristics].

Authors:  Yixin Sun; Hui Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-12-20

10.  [Perioperative Venous Thromboembolism (VTE) Prophalaxis 
in Thoracic Cancer Patients: Chinese Experts Consensus].

Authors:  Hui Li; Gening Jiang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.